Sorrento Therapeutics, Inc. - SRNE
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| First Command Advisory Services, Inc. | History | New | 569 | 0 | — | — | — | +569 | New | Q2 2026 | Aug 10, 2026 |
| Financial Gravity Companies, Inc. | History | New | 18 | 0 | — | — | — | +18 | New | Q2 2026 | Aug 05, 2026 |
| HUNTINGTON NATIONAL BANK | History | No change | 5,001 | 0 | — | — | — | 0 | 0.0% | Q2 2026 | Aug 13, 2026 |
| Oakworth Capital, Inc. | History | No change | 350 | 0 | — | — | — | 0 | 0.0% | Q2 2026 | Jul 22, 2026 |
| Financial Gravity Asset Management, Inc. | History | No change | 18 | 0 | — | — | — | 0 | 0.0% | Q1 2026 | May 08, 2026 |
| VSM Wealth Advisory, LLC | History | No change | 110,100 | 0 | — | — | — | 0 | 0.0% | Q2 2026 | Jul 22, 2026 |